CARD ID | 712 | |
Type of strain | Targeted mutant. | |
Strain name | STOCK-Cacnb3tm1 | |
Internal Code | ccb3 null | |
Submitter | Manabu Murakami | |
Submitter affiliation or code | Department of Pharmacology, Akita University School of Medicine. | |
Stock Type | ||
Material Transfer Conditions |
Consent to us
|
|
Production method | From other organizations | |
Origin (In-house) | Organization | |
Organization code | ||
Developer | ||
Origin (From other organizations) | Organization | Tohoku University School of Medicine |
Organization code | ||
Developer | Teruyuki Yanagisawa | |
Year introduced | 2002 / 7 | |
Introduced Generation | F14 | |
Remarks |
Gene symbol | Cacnb3 |
Gene name | Calcium channel, voltage-dependent, beta 3 subunit |
Allele symbol | |
Allele name | |
MGI | MGI:103307, |
Chromosome | 15 (59.8 ) (15F1) , |
Gene classification | Targeted or trapped gene(knockout etc.) |
Method | Electroporation |
OMIM | OMIM ID: 601958 Human Gene Symbol: CACNB3, |
Gene symbol | Cacnb3 |
Gene name | calcium channel, voltage-dependent, beta 3 subunit |
Allele symbol | |
Allele name | |
MGI | MGI:103307, |
Chromosome | 15 (59.8) (15F1) , |
Gene classification | Targeted or trapped gene(knockout etc.) |
Method | Electroporation |
OMIM | OMIM ID: 601958 Human Gene Symbol: CACNB3, |
GT1 | AGC ACA AAC CTG TGG CAT TTG |
GT2 | TCG GTT GCC AAT GTC ACC CAG |
Author | |
Title | |
Journal | |
Volume | |
Page | |
Year | |
PMID |
Disease name, Applicable field | Physiology |